Isothermal amplification, a family of nucleic acid tests that run at a single constant temperature rather than through the thermal cycling demanded by PCR, is undergoing a quiet transformation driven by nanotechnology. A new review published in Bioscience Nanotechnology examines how magnetic nanoparticles, gold nanostructures, two-dimensional materials such as graphene and MXenes, and catalytic nanozymes are being woven into nearly every step of these assays, from sample preparation to enzyme stabilization to the final optical or electrochemical readout. The authors, led by Sara Colella and Mariarosaria De Falco, argue that this convergence is bridging the gap between laboratory precision and field-scale testing.
The appeal of isothermal amplification lies in its operational simplicity. Reactions proceed at fixed temperatures, for example 25, 37 or 65 degrees Celsius, eliminating the need for thermal denaturation steps and reducing assay times from hours to minutes. A simple heating block or portable incubator can replace bulky, energy-intensive laboratory infrastructure. Established chemistries include loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), nucleic acid sequence-based amplification (NASBA) and helicase-dependent amplification (HDA), each relying on distinct enzymatic pathways to generate rapid, sensitive and specific signals. The review notes that these reactions also tolerate inhibitors better than standard qPCR, which often requires high-purity templates, whereas nano-assisted versions can perform well in crude matrices such as saliva, whole blood and wastewater, often delivering results within 15 to 30 minutes.
Sample preparation remains one of the principal bottlenecks in nucleic acid diagnostics, particularly for isothermal platforms whose robustness depends strongly on template quality. Conventional extraction involves cell lysis, enzymatic digestion, repeated centrifugation and column-based purification, all labor-intensive steps tied to laboratory instrumentation. Nanomaterials offer an alternative: their high surface-to-volume ratio and tunable surface chemistry enable integrated lysis, capture, concentration and purification within simplified workflows. Magnetic nanoparticles, typically iron oxide cores with functionalized shells, can capture nucleic acids directly from blood, saliva, urine, food or environmental water and be separated with a simple magnetic rack, no centrifugation required. In some implementations, captured DNA goes straight into the amplification reaction without elution, further shortening turnaround time.
Nanomaterials also stabilize the enzymes on which these assays depend. Gold nanoparticles can generate protective nano-interfaces that reduce enzyme denaturation, aggregation and nonspecific adsorption, extending reagent shelf-life and keeping activity consistent under fluctuating field conditions. Immobilizing enzymes or primers on such surfaces through covalent or affinity-based conjugation improves storage stability and resistance to proteolytic degradation, although the authors caution that immobilization can introduce steric hindrance and altered reaction kinetics depending on the strategy used. Carbon-based nanomaterials, including graphene oxide, carbon nanotubes and MXenes, contribute high thermal conductivity that homogenizes temperature distribution in miniaturized reactions, while nanozymes, inorganic structures with enzyme-mimetic activity, are being explored as robust, cold-chain-independent alternatives to biological enzymes.
Some of the most striking examples come from optical biosensing. Chen and colleagues developed a LAMP assay coupled to a lateral flow biosensor for screening Chlamydia trachomatis, using gold nanoparticles as visual markers whose localized surface plasmon resonance produces a vivid red readout visible to the naked eye. The assay achieved a detection limit of 50 copies per milliliter and a complete workflow in under 60 minutes at a constant 67 degrees Celsius. Xiao and colleagues reported a similar lateral flow system operating at 64 degrees Celsius that detected as few as 5 copies of DNA target per reaction within an hour, with nanoparticle-labeled probes ensuring that only successfully amplified target DNA produced a signal, reducing false positives from primer dimers.
An even simpler approach dispenses with functionalized probes altogether. Carlos and colleagues used non-functionalized gold nanoparticles as a colorimetric reporter: in a positive reaction, the abundant double-stranded DNA shields the particles from salt-induced aggregation and the solution stays red, while in a negative reaction the particles aggregate and shift to blue. This yes-or-no visual readout reduces chemical complexity and reagent degradation, advantages for field conditions. Beyond signaling, gold nanoparticles have been shown to act as specificity boosters, suppressing nonspecific primer-dimer formation and minimizing mismatch extension, elevating SNP diagnostic accuracy to levels previously requiring high-resolution melting or sequencing.
The toolkit extends well beyond gold. Qu and colleagues built an electrochemical biosensor for circulating tumor DNA carrying the EGFR L858R mutation, in which silver-ion-mediated nanospheres release a high density of silver ions upon target recognition, triggering a secondary cation exchange with copper sulfide nanoparticles that liberates electrochemical messengers, a cascade suited to liquid biopsies where mutant DNA is masked by a high background of healthy DNA. Orsini and colleagues configured a fluorescent system in which biotinylated, cyanine-labeled amplicons bind streptavidin-coated magnetic nanoparticles and are pulled onto micro-magnet lines inside an 18-chamber cartridge, concentrating the signal into high-contrast fluorescent lines and separating target DNA from unincorporated primers. Li and colleagues applied magnetic nanoparticle-assisted multiplex RPA to simultaneously detect horse and chicken mitochondrial genes for meat authentication, and Zeng and colleagues combined RPA with CRISPR-Cas12a and core-shell quantum dot labels on lateral flow strips to detect Escherichia coli O157:H7 and Listeria monocytogenes with high photostability and sensitivity.
At the point-of-care frontier, Wei and colleagues developed a plasmonic-enhanced digitizing biosensor in which a nano-array of gold discs creates localized electromagnetic field enhancement, amplifying fluorescence from LAMP amplicons confined in micro-chambers. Counting discrete digital amplification spots in real time, the system reached a detection limit of 1 copy per microliter, matching the sensitivity of digital PCR while retaining the speed and simplicity of an isothermal process, and its signal boost allows use of lower-power optical components compatible with handheld devices. MXenes are also emerging: titanium carbide MXene nanosheets have served as conductive substrates in electrochemiluminescence sensing and as efficient quenchers in mix-and-detect RPA workflows for DNA methylation, where their broad metallic absorption lowers background fluorescence.
The review is candid about the obstacles standing between laboratory prototypes and commercial products. Batch-to-batch reproducibility of nanomaterial synthesis and surface functionalization remains a key challenge, since small variations in particle size, surface charge or ligand density can alter binding kinetics and optical or electrochemical responses. Visual colorimetric outputs are inefficient for quantification, and variations in illumination or camera resolution can affect signal linearity, while electrochemical detection may not match the sensitivity and accuracy of PCR. Biocompatibility, long-term stability and potential cytotoxicity of nanomaterials require careful evaluation, and closed-cartridge integration must prevent amplicon contamination and meet biosafety standards such as ISO 13485 and FDA 510(k). Widespread adoption will also demand large-scale validation in real clinical matrices and inter-laboratory comparison studies. The authors observe that most reported systems rely on LAMP chemistry, predominantly paired with gold nanoparticles.
Looking ahead, the authors envision hybrid nanostructures such as plasmonic-magnetic composites and MXene-graphene heterostructures that simultaneously support sample preparation, enzyme stabilization and signal generation, alongside roll-to-roll printed single-use cartridges paired with smartphone analytics and machine learning, and eventually Internet of Things frameworks for distributed biosensor networks in health surveillance and epidemic monitoring. Realizing that vision, they note, will require standardized protocols for data management, test calibration and device communication, plus ethical frameworks for sensitive diagnostic information. Their conclusion is that the synergy between nanotechnology and isothermal chemistry has moved the field from experimental proof-of-concept to robust, field-deployable tools, with next-generation all-in-one platforms combining magnetic sample preparation and digital nanostructured readout poised to eliminate the sample-to-result bottleneck that still hampers many point-of-care devices.
Subject of Research: Integration of nanomaterials with isothermal nucleic acid amplification for point-of-care molecular diagnostics
Article Title: Nanotechnology-driven evolution of isothermal amplification diagnostics
Article References: Colella, S., AbdelkarimAbdelkarim, J. Y., Antonacci, A., Nocerino, V., Miranda, B., De Stefano, L., Fiorentino, G., De Felice, M., Scognamiglio, V., & De Falco, M. (2026). Nanotechnology-driven evolution of isothermal amplification diagnostics. Bioscience Nanotechnology, 2(1), Article 16. https://doi.org/10.1186/s44331-026-00023-9
Image Credits: AI Generated
DOI: 10.1186/s44331-026-00023-9
Keywords: isothermal amplification, nanotechnology, gold nanoparticles, magnetic nanoparticles, LAMP, RPA, MXenes, biosensors, point-of-care diagnostics, lateral flow assay, nanozymes, molecular diagnostics
News Source: Charles Cole. (October 29, 2026). Gold, Magnets and MXenes: How Nanomaterials Are Rewriting Rapid DNA Diagnostics. Scienmag.



